Related references
Note: Only part of the references are listed.Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin
J Chen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2006)
Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats
J Chen et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs
XY Sha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Development and characterization of a novel liposome-based formulation of SN-38
JA Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors
LL Jung et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Camptothecins - A review of their chemotherapeutic potential
H Ulukan et al.
DRUGS (2002)
Preparation and characterization of camptothecin solid lipid nanoparticles
SC Yang et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: A potential alternative for HIV-Infection/AIDS therapy
CL Hung et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
Share Paper
